1065 ACTM-838, a Microbial-Based Immunotherapy That Enriches in Solid Tumors after IV Dosing, Reverses the Immunosuppressive TME to Promote Durable Anti-Tumor Immunity, Alone and in Combination with Anti-Pd1 in Mice
Regular and Young Investigator Award Abstracts(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined